Read + Share
Chen M, Fu M, Wang A, Wu X, et al. Cytoplasmic CD79a is a promising biomarker for B lymphoblastic leukemia follow up
post CD19 CAR-T therapy. Leuk Lymphoma 2021 Oct 21:1-9. doi: 10.1080/10428194.2021.1980214.
PMID: 34672246
|
 |
|
Chen M, Fu M, Wang A, Wu X, et al. Cytoplasmic CD79a is a promising biomarker for B lymphoblastic leukemia follow up
post CD19 CAR-T therapy. Leuk Lymphoma 2021 Oct 21:1-9. doi: 10.1080/10428194.2021.1980214.
PMID: 34672246
|
|
|
|